TrialJournal of endocrinological investigation2001

Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.

J Pachucki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.